AVIR - Atea Pharmaceuticals Inc. (AVIR) Q1 2024 Earnings Call Transcript
2024-05-14 22:00:23 ET
Atea Pharmaceuticals, Inc. (AVIR)
Q1 2024 Earnings Conference Call
May 14, 2024 4:30 PM ET
Company Participants
Jonae Barnes - Senior Vice President of Investor Relations and Corporate Communications
Jean-Pierre Sommadossi - Founder and Chief Executive Officer
Arantxa Horga - Chief Medical Officer
Janet Hammond - Chief Development Officer
John Vavricka - Chief Commercial Officer
Andrea Corcoran - Chief Financial Officer and Executive Vice President of Legal
Conference Call Participants
Maxwell Skor - Morgan Stanley
Jonathan Miller - Evercore ISI
Tim Lugo - William Blair
Rosa Chen - Leerink Partners
Presentation
Operator
Good afternoon, everyone, and welcome to the Atea Pharmaceuticals First Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in listen-only mode. Following the formal remarks, we will open the call up for your questions.
I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Ms. Barnes, please proceed.
Jonae Barnes
Thank you, and good afternoon, everyone, and welcome to Atea Pharmaceutical's first quarter 2024 financial results and business update conference call. Earlier today, we issued a press release which outlines the topics we plan to discuss. You can access the press release as well as the slides we'll be reviewing today by going to the investor section of our website at ir.ateapharma.com....
Atea Pharmaceuticals, Inc. (AVIR) Q1 2024 Earnings Call Transcript